Illness	Number of cases
Malignant neoplasm of prostate (C61)	119
Hyperplasia of prostate (N40)	68
Inflammatory diseases of prostate - Chronic prostatitis (N41.1)	15
Other disorders of prostate (N42.3)	5
Carcinoma in situ of other and unspecified genital organs - Carcinoma in situ of prostate (D07.5)	not specified
Neoplasm of uncertain or unknown behaviour of male genital organs - Neoplasm of uncertain behavior of prostate (D40.0)	not specified
Other disorders of prostate (N42.2)	not specified
Other specified abnormalities of plasma proteins (R77.80)	not specified

Top 10 treatments

Treatment	Number
Taking a tissue sample (biopsy) of the kidney, urinary tract or male reproductive organs through the skin, guided by imaging procedures such as ultrasound (1-465.8)	212
Injection or administration of medicines into the urinary bladder (8-132.x)	205
Regional pain control by injecting an anaesthetic into a space in the spinal canal (subarachnoid space) (8-911)	24
Examination of the urethra and the urinary bladder by endoscopy (1-661)	0
Injection or administration of medicines into the urinary bladder (8-132.3)	0
(9-984.6)	0
(9-984.8)	0

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
7	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
7	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
5	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility